FDA Approves Multiple Sclerosis Drug Lemtrada

November 16, 2014 6:13 AM

10 0

The U.S. Food and Drug Administration approved on Saturday the multiple sclerosis drug Lemtrada to be sold in the United States.

Lemtrada can now be used in the treatment of individuals who suffer from relapsing forms of MS.

Also read: FDA OKs 2nd gene therapy for blood cancer; 1st for adults

Read more

To category page